Stress-based animal models of depression: Do we actually know what we are doing?

Brain Research

Volumn 1652, Issue , 2016, Pages 30-42

  Yin, Xin ^a   Guven, Nuri ^a   Dietis, Nikolas ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Animal models of depression Learned helplessness; Chronic mild stress; Depression; Forced swimming test

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CHRONIC MILD STRESS; CHRONIC STRESS; CONSTRUCT VALIDITY; DEPRESSION; DISEASE MODEL; DRUG RESEARCH; DRUG SCREENING; EXPERIMENTAL DEPRESSION TEST; FACE VALIDITY; FORCED SWIM TEST; LEARNED HELPLESSNESS; METHODOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TAIL SUSPENSION TEST; TREATMENT OUTCOME; ANIMAL; HUMAN; MENTAL STRESS;

ANIMALS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HUMANS; STRESS, PSYCHOLOGICAL;

EID: 84991619033     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.09.027     Document Type: Review

References (196)

1. Abramson, L.Y., Seligman, M.E., Teasdale, J.D., Learned helplessness in humans: critique and reformulation. J. Abnorm. Psychol. 87 (1978), 49–74.
2. Aguilar, M.A., Minarro, J., Simon, V.M., Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol. Learn. Mem. 69 (1998), 92–105.
3. Al-Hasani, R., McCall, J.G., Bruchas, M.R., 2013. Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference.
4. Amat, J., et al. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 8 (2005), 365–371.
5. Amat, J., et al. Behavioral control over shock blocks behavioral and neurochemical effects of later social defeat. Neuroscience 165 (2010), 1031–1038.
6. Angst, J., Angst, F., Stassen, H., Suicide risk in patients with major depressive disorder. J. Clin. Psychiatry, 60(1), 1999 478-62.
7. Anisman, H., et al. Cross-stressor immunization against the behavioral deficits introduced by uncontrollable shock. Behav. Neurosci., 97, 1983, 452.
8. Arai, I., et al. Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. Pharmacol. Res. 42 (2000), 171–176.
9. Artigas, F., Limitations to enhancing the speed of onset of antidepressants—are rapid action antidepressants possible? Human. Psychopharmacol.: Clin. Exp. 16 (2001), 29–36.
10. Baamonde, A., et al. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation. Eur. J. Pharmacol. 216 (1992), 157–166.
11. Bair, M.J., et al. Depression and pain comorbidity: A literature review. Arch. Intern. Med. 163 (2003), 2433–2445.
12. Barros, H.M., Ferigolo, M., Ethopharmacology of imipramine in the forced-swimming test: gender differences. Neurosci. Biobehav. Rev. 23 (1998), 279–286.
13. Bergström, A., et al. Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression—a gene expression study. J. Mol. Neurosci. 33 (2007), 201–215.
14. Bessa, J.M., et al. A trans-dimensional approach to the behavioral aspects of depression. Front. Behav. Neurosci., 3, 2009, 1.
15. Besson, A., et al. Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats. Psychopharmacology 123 (1996), 71–78.
16. Betin, C., et al. Further characterization of the behavioral despair test in mice: positive effects of convulsants. Physiol. Behav. 28 (1982), 307–311.
17. Boice, R., Some behavioral tests of domestication in Norway rats. Behaviour 42 (1972), 198–230.
18. Borsini, F., Meli, A., Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988), 147–160.
19. Borsini, F., Volterra, G., Meli, A., Does the behavioral “despair” test measure "despair"?. Physiol. Behav. 38 (1986), 385–386.
20. Bourin, M., et al. Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. J. Psychiatry Neurosci., 27, 2002, 178.
21. Bremner, J.D., McCaffery, P., The neurobiology of retinoic acid in affective disorders. Progress Neuro-Psychopharmacol. Biol. Psychiatry 32 (2008), 315–331.
22. Brenes, J.C., Fornaguera, J., The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum. Behav. Brain Res. 198 (2009), 199–205.
23. Browne, R.G., Effects of antidepressants and anticholinergics in a mouse “behavioral despair” test. Eur. J. Pharmacol. 58 (1979), 331–334.
24. Browne, R.G., Effects of antidepressants and anticholinergics in a mouse ‚Äúbehavioral despair‚Äù test. Eur. J. Pharmacol. 58 (1979), 331–334.
25. Carr, G.V., et al. Antidepressant-like effects of κ-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology 35 (2009), 752–763.
26. Carr, G.V., et al. Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology 35 (2010), 752–763.
27. Carter, G.T., Sullivan, M.D., Antidepressants in pain management. Curr. Opin. Investig. Drugs 3 (2002), 454–458.
28. Castagné, V., et al. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci., 2011, 14 8.10 A. 1-8.10 A.
29. Chan, H.N., Fam, J., Ng, B.Y., Use of antidepressants in the treatment of chronic pain. Ann. Acad. Med. Singapore 38 (2009), 974–979.
30. Chourbaji, S., et al. Learned helplessness: validity and reliability of depressive-like states in mice. Brain Res. Protoc. 16 (2005), 70–78.
31. Christiansen, S., et al. Circadian activity of the hypothalamic–pituitary–adrenal axis is differentially affected in the rat chronic mild stress model of depression. Stress 15 (2012), 647–657.
32. Crema, L.M., et al. The effect of unpredictable chronic mild stress on depressive-like behavior and on hippocampal A1 and striatal A2A adenosine receptors. Physiol. Behav. 109 (2013), 1–7.
33. Cryan, J.F., Mombereau, C., In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol. Psychiatry 9 (2004), 326–357.
34. Cryan, J.F., Markou, A., Lucki, I., Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23 (2002), 238–245.
35. Cryan, J.F., Mombereau, C., Vassout, A., The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 29 (2005), 571–625.
36. Cryan, J.F., Valentino, R.J., Lucki, I., Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 29 (2005), 547–569.
37. Czéh, B., et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl Acad. Sci. 98 (2001), 12796–12801.
38. de Kloet, E., Molendijk, M., Coping with the Forced swim stressor: towards understanding an adaptive mechanism. Neural Plastic., 2016, 2016.
39. Darko, D.F., et al. Association of beta-endorphin with specific clinical symptoms of depression. Am. J. Psychiatry 149 (1992), 1162–1167.
40. de Felipe, M.C., et al. Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. Eur. J. Pharmacol. 159 (1989), 175–180.
41. De Pablo, J.M., et al. Learned immobility explains the behavior of rats in the forced swimming test. Physiol. Behav. 46 (1989), 229–237.
42. Der-Avakian, A., Markou, A., The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 35 (2012), 68–77.
43. Detke, M.J., Rickels, M., Lucki, I., Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995), 66–72.
44. Dinan, T.G., Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br. J. Psychiatry 164 (1994), 365–371.
45. Djurovic, D., Milic-Askrabic, J., Majkic-Singh, N., Serum beta-endorphin level in patients with depression on fluvoxamine. Farmaco 54 (1999), 130–133.
46. Drugan, R.C., et al. Analysis of the importance of controllable versus uncontrollable stress on subsequent behavioral and physiological functioning. Brain Res. Protoc. 2 (1997), 69–74.
47. Duda, W., et al. The Effect of chronic mild stress and imipramine on the markers of oxidative stress and antioxidant system in rat liver. Neurotox. Res., 2016, 1–12.
48. Dumont, M., Provost, M.A., Resilience in adolescents: Protective role of social support, coping strategies, self-esteem, and social activities on experience of stress and depression. J. Youth Adolesc. 28 (1999), 343–363.
49. Dunn, A.J., Swiergiel, A.H., de Beaurepaire, R., Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 29 (2005), 891–909.
50. Dweck, C.S., The role of expectations and attributions in the alleviation of learned helplessness. J. Personal. Soc. Psychology, 31, 1975, 674.
51. Fava, M., Kendler, K.S., Major depressive disorder. Neuron 28 (2000), 335–341.
52. Fedotova, J., Effects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats. ISRN Pharmacol., 2012, 2012, 305645.
53. Feng, S.F., et al. Long-lasting effects of chronic rTMS to treat chronic rodent model of depression. Behav. Brain Res. 232 (2012), 245–251.
54. First, M., et al. The effects of reboxetine treatment on depression-like behavior, brain neurotrophins, and ERK expression in rats exposed to chronic mild stress. J. Mol. Neurosci. 50 (2013), 88–97.
55. Forbes, E.E., et al. Healthy adolescents' neural response to reward: associations with puberty, positive affect, and depressive symptoms. J. Am. Acad. Child Adolesc. Psychiatry 49 (2010), 162–172 e5.
56. Frazer, A., Morilak, D.A., What should animal models of depression model?. Neurosci. Biobehav. Rev/ 29 (2005), 515–523.
57. Frisbee, J., et al. An unpredictable chronic mild stress protocol for instigating depressive symptoms, behavioral changes and negative health outcomes in rodents. J. Vis. Exp. JoVE., 2014.
58. Garcia-Marquez, C., Armario, A., Chronic stress depresses exploratory activity and behavioral performance in the forced swimming test without altering ACTH response to a novel acute stressor. Physiol. Behav. 40 (1987), 33–38.
59. Gavioli, E., et al. Blockade of nociceptin/orphanin FQ‚ÄìNOP receptor signalling produces antidepressant‚Äêlike effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur. J. Neurosci. 17 (2003), 1987–1990.
60. Gavioli, E.C., et al. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch. Pharmacol. 369 (2004), 547–553.
61. Gibert-Rahola, J., et al. RB 38 B, a selective neutral endopeptidase inhibitor, induced reversal off escape deficits caused by inescapable shocks pretreatment in rats. Eur. J. Pharmacol. 183 (1990), 2317–2318.
62. Gold, S.M., Irwin, M.R., Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Neurologic Clin. 24 (2006), 507–519.
63. Górka, Z., Janus, K., Effects of neuroleptics displaying antidepressant activity on behavior of rats in the forced swimming test. Pharmacol. Biochem. Behav. 23 (1985), 203–206.
64. Grahn, R.E., Watkins, L.R., Maier, S.F., Impaired escape performance and enhanced conditioned fear in rats following exposure to an uncontrollable stressor are mediated by glutamate and nitric oxide in the dorsal raphe nucleus. Behav. Brain Res. 112 (2000), 33–41.
65. Greenwood, B.N., et al. Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus. Neuroscience 144 (2007), 1193–1208.
66. Grønli, J., et al. Chronic mild stress affects sucrose intake and sleep in rats. Behav. Brain Res. 150 (2004), 139–147.
67. Gutman, D.A., Nemeroff, C.B., Stress and depression. The handbook of stress science: Biology. Psychol. Health, 2011, 345–357.
68. Hajszan, T., et al. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol. Psychiatry 65 (2009), 392–400.
69. Hales, S.A., et al. Cognitions in bipolar affective disorder and unipolar depression: imagining suicide. Bipolar Disord. 13 (2011), 651–661.
70. Hammen, C., Stress and depression. Annu. Rev. Clin. Psychol. 1 (2005), 293–319.
71. Hill, M.N., et al. Neurobiology of chronic mild stress: parallels to major depression. Neurosci. Biobehav. Rev. 36 (2012), 2085–2117.
72. Holanda, V.A., et al. Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness. Psychopharmacology (Berl.) 233 (2016), 2525–2532.
73. Hozumi, S., et al. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav. Brain Res. 138 (2003), 9–15.
74. Hudzik, T.J., et al. Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor. J. of Pharmacol. Exp. Therapeutics 338 (2011), 195–204.
75. Jang, C.G., et al. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom. Arch. Pharm. Res. 27 (2004), 1065–1072.
76. Jayatissa, M.N., et al. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 31 (2006), 2395–2404.
77. Ji, M.J., et al. Hippocampal PPARdelta overexpression or activation represses stress-induced depressive behaviors and enhances neurogenesis. Int. J. Neuropsychopharmacol., 19, 2016.
78. Joca, S.R.L., Padovan, C.M., Guimaraes, F.S., Activation of post-synaptic 5-HT 1A receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res. 978 (2003), 177–184.
79. Johnson, S.A., Fournier, N.M., Kalynchuk, L.E., Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav. Brain Res. 168 (2006), 280–288.
80. Jutkiewicz, E.M., et al. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. J. Pharmacol. Exp. Ther., 309, 2004 173-81. Epub 2004 Jan 13.
81. Jutkiewicz, E.M., et al. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology (Berl.) 182 (2005), 588–596.
82. Karson, A., et al. Chronic Administration of Infliximab (TNF‐α Inhibitor) decreases depression and anxiety‐like behaviour in rat model of chronic mild stress. Basic Clin. Pharmacol. Toxicol. 112 (2013), 335–340.
83. Katz, R.J., Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16 (1982), 965–968.
84. Kelly, J., Wrynn, A., Leonard, B., The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Therapeutics 74 (1997), 299–316.
85. Khursheed, R., et al. Antidepressant effect and categorization of Inhibitory activity of monoamine oxidase type A and B of ethanolic extract of seeds of Trigonella foenum graecum Linn. Pak. J. Pharm. Sci. 27 (2014), 1419–1425.
86. Kita, A., et al. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats. Jpn. J. Pharmacol. 75 (1997), 337–346.
87. Koch, S., et al. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27 (2002), 949–959.
88. Krishnan, V., Nestler, E.J., The molecular neurobiology of depression. Nature 455 (2008), 894–902.
89. Krishnan, V., Nestler, E.J., Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 167 (2010), 1305–1320.
90. Lee, T.-H., et al. Treadmill exercise alleviates chronic mild stress-induced depression in rats. J. Exer. Rehabilit., 11, 2015, 303.
91. Li, L.F., et al. Antidepressant‐like Effect of Magnolol on BDNF Up‐regulation and Serotonergic System Activity in Unpredictable Chronic Mild Stress Treated Rats. Phytother. Res. 26 (2012), 1189–1194.
92. Li, X., et al. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. J. Pharmacol. Exp. Therap. 319 (2006), 254–259.
93. Li, Y.C., et al. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009), 435–449.
94. Lucki, I., The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8 (1997), 523–532.
95. Lucki, I., Dalvi, A., Mayorga, A.J., Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155 (2001), 315–322.
96. Luo, D., An, S., Zhang, X., Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res. Bull. 77 (2008), 8–12.
97. Maier, S.F., Learned helplessness and animal models of depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 8 (1984), 435–446.
98. Maier, S.F., Exposure to the stressor environment prevents the temporal dissipation of behavioral depression/learned helplessness. Biol. Psychiatry 49 (2001), 763–773.
99. Maier, S.F., Seligman, M.E., Learned helplessness: Theory and evidence. J. Exp. Psychol.: Gen., 105, 1976, 3.
100. Maier, S.F., Watkins, L.R., Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 29 (2005), 829–841.
101. Marcus, M., et al., 2012. Depression: a global public health concern. Vol., W.D.o.M.H.a.S. Abuse, ed.eds.
102. Melo, A., et al. The positive effect on ketamine as a priming adjuvant in antidepressant treatment. Translat. Psychiatry, 5, 2015, e573.
103. Monleon, S., et al. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117 (1995), 453–457.
104. Moscarello, J.M., LeDoux, J.E., Active avoidance learning requires prefrontal suppression of amygdala-mediated defensive reactions. J. Neurosci. 33 (2013), 3815–3823.
105. Moussavi, S., et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370 (2007), 851–858.
106. Mucignat-Caretta, C., Caretta, A., Animal models of depression: olfactory lesions affect amygdala, subventricular zone, and aggression. Neurobiol. Dis. 16 (2004), 386–395.
107. Muscat, R., Willner, P., Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci. Biobehav. Rev. 16 (1992), 507–517.
108. Mutlu, O., et al. Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice. Pharmacol. Biochem. Behav. 92 (2009), 82–87.
109. Mutlu, O., et al. Effects of fluoxetine, tianeptine and olanzapine on unpredictable chronic mild stress-induced depression-like behavior in mice. Life Sci. 91 (2012), 1252–1262.
110. Nagatani, T., Sugihara, T., Kodaira, R., The effect of diazepam and of agents which change GABAergic functions in immobility in mice. Eur. J. Pharmacol. 97 (1984), 271–275.
111. Nestler, E.J., Hyman, S.E., Animal models of neuropsychiatric disorders. Nat. Neurosci. 13 (2010), 1161–1169.
112. Nieto, M.M., et al. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135 (2005), 305–313.
113. Nikseresht, S., et al. Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice. Arch. Iran Med. 15 (2012), 306–311.
114. Nishimura, H., et al. Is immobility of rats in the forced swim test "behavioral despair?". Physiol. Behav. 42 (1988), 93–95.
115. Nishimura, H., et al. Is immobility of rats in the forced swim test “behavioral despair?”. Physiol. Behav. 42 (1988), 93–95.
116. Nollet, M., Guisquet, A.M.L., Belzung, C., Models of depression: unpredictable chronic mild stress in mice. Curr. Protoc. Pharmacol.(17), 2013 5.65. 1-5.65.
117. Nowak, G., et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res. Bull. 61 (2003), 159–164.
118. O'Reilly, K., Bailey, S.J., Lane, M.A., Retinoid-mediated regulation of mood: possible cellular mechanisms. Exp. Biol. Med. (Maywood) 233 (2008), 251–258.
119. Overstreet, D.H., The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17 (1993), 51–68.
120. Overstreet, D.H., Wegener, G., The flinders sensitive line rat model of depression—25 years and still producing. Pharmacol. Rev. 65 (2013), 143–155.
121. Page, M.E., et al. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147 (1999), 162–167.
122. Papp, M., et al. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28 (2003), 694–703.
123. Papp, M., et al. Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats. Psychopharmacology, 2016, 1–9.
124. Papp, M., Moryl, E., Willner, P., Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol. 296 (1996), 129–136.
125. Pariante, C.M., Depression, stress and the adrenal axis. J. Neuroendocrinol. 15 (2003), 811–812.
126. Pariante, C.M., Lightman, S.L., The HPA axis in major depression: classical theories and new developments. Trend. Neurosci. 31 (2008), 464–468.
127. Paris, J., The mistreatment of major depressive disorder. Can. J. Psychiatry 59 (2014), 148–151.
128. Patterson, P.H., Maternal infection and immune involvement in autism. Trend. Mol. Med. 17 (2011), 389–394.
129. Peterson, C., 1993. Learned helplessness, Vol., Wiley Online Library.
130. Petit-Demouliere, B., Chenu, F., Bourin, M., Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177 (2005), 245–255.
131. Petty, F., Kramer, G., Wilson, L., Prevention of learned helplessness: in vivo correlation with cortical serotonin. Pharmacol. Biochem. Behav. 43 (1992), 361–367.
132. Pochwat, B., et al. Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int. J. Neuropsychopharmacol. 17 (2014), 393–405.
133. Porsolt, R.D., Le Pichon, M., Jalfre, M., Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977), 730–732.
134. Porsolt, R.D., Bertin, A., Jalfre, M., Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn Ther. 229 (1977), 327–336.
135. Porsolt, R.D., Bertin, A., Jalfre, M., “Behavioural despair” in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 51 (1978), 291–294.
136. Price, K.P., Geer, J.H., Predictable and unpredictable aversive events: Evidence for the safety-signal hypothesis. Psychonomic Sci. 26 (1972), 215–216.
137. Pryce, C.R., Seifritz, E., A translational research framework for enhanced validity of mouse models of psychopathological states in depression. Psychoneuroendocrinology 36 (2011), 308–329.
138. Pucilowski, O., et al. Effects of acute and chronic stressors on saccharin preference in hypercholinergic rats. Behav. Pharmacol., 3, 1992, 50.
139. Redrobe, J.P., Regoli, D., Quirion, Rm, Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn-Schmiedeberg's Arch. Pharmacol. 365 (2002), 164–167.
140. Reed, A.L., et al. Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Psychopharmacology 205 (2009), 249–259.
141. Reindl, J.D., et al. Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test. Pharmacology 81 (2008), 229–235.
142. Rénéric, J.-P., Bouvard, M., Stinus, L., In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs. Behav. Brain Res. 136 (2002), 521–532.
143. Réus, G.Z., et al. Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab. Brain Dis. 27 (2012), 175–182.
144. Rizzi, A., et al. Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. Neuropharmacology 60 (2011), 572–579.
145. Saitoh, A., et al. Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J. Pharmacol. Sci. 95 (2004), 374–380.
146. Saitoh, A., Yamada, M., Antidepressant-like effects of delta opioid receptor agonists in animal models. Curr. Neuropharmacol. 10 (2012), 231–238.
147. Salavecz, G., Stauder, A., Purebl, G., 2014. Work related stress and depression.
148. Salehi-Sadaghiani, M., et al. NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice. Psychopharmacology (Berl.) 223 (2012), 345–355.
149. Sanchez, C., Gruca, P., Papp, M., R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Behav. Pharmacol. 14 (2003), 465–470.
150. Sartori, S., et al. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology 62 (2012), 304–312.
151. Scharf, S.H., Schmidt, M.V., Animal models of stress vulnerability and resilience in translational research. Curr. Psychiatry Rep. 14 (2012), 159–165.
152. Schmidt, M., et al. Morc1 knockout evokes a depression-like phenotype in mice. Behav. Brain Res. 296 (2016), 7–14.
153. Schulteis, G., Martinez, J.L. Jr, ICI 174,864, a selective delta opioid antagonist, reverses the learning impairment produced by [leu] enkephalin. Psychopharmacology 100 (1990), 102–109.
154. Segev, A., et al. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. Neuropsychopharmacology 39 (2014), 919–933.
155. Seligman, M.E., Chronic fear produced by unpredictable electric shock. J. Comp. Physiolog. Psychol., 66, 1968, 402.
156. Seligman, M.E., Maier, S.F., Failure to escape traumatic shock. J. Exp. Psychol., 74, 1967, 1.
157. Seligman, M.E., Maier, S.F., Geer, J.H., Alleviation of learned helplessness in the dog. J. Abnorm. Psychol. 73 (1968), 256–262.
158. Sherman, A.D., Sacquitne, J., Petty, F., Specificity of the learned helplessness model of depression. Pharmacol. Biochem. Behav. 16 (1982), 449–454.
159. Shirayama, Y., et al. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects. J. Neurochem. 90 (2004), 1258–1268.
160. Slattery, D.A., Cryan, J.F., Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 7 (2012), 1009–1014.
161. Steenbergen, H.L., et al. Sex-dependent effects of inescapable shock administration on shuttlebox-escape performance and elevated plus-maze behavior. Physiol. Behav. 48 (1990), 571–576.
162. Stein, C., et al. Peripheral mechanisms of pain and analgesia. Brain Res. Rev. 60 (2009), 90–113.
163. Strauss, G.P., Gold, J.M., A new perspective on anhedonia in schizophrenia. Am. J. Psychiatry, 2012.
164. Strekalova, T., et al. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 29 (2004), 2007–2017.
165. Su, J., et al. A test–retest paradigm of the forced swimming test in female mice is not valid for predicting antidepressant-like activity: participation of acetylcholine and Sigma-1 receptors. J. Pharmacol. Sci. 123 (2013), 246–255.
166. Sunal, R., Gumusel, B., Kayaalp, S., Effect of changes in swimming area on results of ‚Äúbehavioral despair test‚Äù. Pharmacol. Biochem. Behav. 49 (1994), 891–896.
167. Takamori, K., Yoshida, S., Okuyama, S., Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats. Pharmacology 63 (2001), 147–153.
168. Taltavull, J., et al. Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim. Brain Res. 975 (2003), 244–247.
169. Tejedor-Real, P., et al. Involvement of δ-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur. J. Pharmacol. 354 (1998), 1–7.
170. Tohda, M., Mingmalairak, S., Evidence of antidepressive effects of a wakan-yaku, hochuekkito, in depression model mice with learned-helplessness behavior. Evid. Based Complement Alternat. Med., 2013, 2013, 319073.
171. Torregrossa, M.M., et al. Chronic administration of the delta opioid receptor agonist (+) BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology 183 (2005), 31–40.
172. Torregrossa, M.M., et al. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Res. 1069 (2006), 172–181.
173. Udina, M., et al. Cytokine-induced depression: current status and novel targets for depression therapy. CNS Neurol. Disord. Drug Targets 13 (2014), 1066–1074.
174. Van Winkel, R., Stefanis, N.C., Myin-Germeys, I., Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophrenia Bull. 34 (2008), 1095–1105.
175. Vancassel, S., et al. n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. J. Lipid Res. 49 (2008), 340–348.
176. Veldhuis, H.D., De Korte, C.C., De Kloet, E.R., Glucocorticoids facilitate the retention of acquired immobility during forced swimming. Eur. J. Pharmacol. 115 (1985), 211–217.
177. Vergura, R., et al. Dmt-Tic-NH-CH 2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies. Peptides 27 (2006), 3322–3330.
178. Vergura, R., et al. Anxiolytic-and antidepressant-like activities of H-Dmt-Tic-NH-CH (CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29 (2008), 93–103.
179. Vitale, G., et al. Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology 207 (2009), 173–189.
180. Vitale, G., et al. Chronic treatment with the selective NOP receptor antagonist [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology 207 (2009), 173–189.
181. Vollmayr, B., Henn, F.A., Learned helplessness in the rat: improvements in validity and reliability. Brain Res. Protoc. 8 (2001), 1–7.
182. Vollmayr, B., Gass, P., Learned helplessness: unique features and translational value of a cognitive depression model. Cell Tissue Res. 354 (2013), 171–178.
183. Vollmayr, B., Mahlstedt, M.M., Henn, F.A., Neurogenesis and depression: what animal models tell us about the link. Eur. Arch. Psychiatry Clin. Neurosci. 257 (2007), 300–303.
184. West, A.P., Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 14, 1990 863IN3–877IN4.
185. WHO, 2012. Estimates of cause-specific mortality for 2000–2012. Vol., ed.^eds.
186. Wiborg, O., Chronic mild stress for modeling anhedonia. Cell Tissue Res. 354 (2013), 155–169.
187. Willner, P., Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 10 (1986), 677–690.
188. Willner, P., Mitchell, P.J., The validity of animal models of predisposition to depression. Behav. Pharmacol. 13 (2002), 169–188.
189. Willner, P., Muscat, R., Papp, M., Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 16 (1992), 525–534.
190. Xue, R., et al. The discovery of 071031B, a novel serotonin and noradrenaline reuptake inhibitor. Neurosci. Lett. 544 (2013), 68–73.
191. y Palacios, R.D., et al. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol. Psychiatry 70 (2011), 449–457.
192. Yalcin, I., et al. Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system. Behav. Pharmacol. 18 (2007), 623–631.
193. Yan, S., et al. Antidepressant-like effects of Sanyuansan in the mouse forced swim test, tail suspension test, and chronic mild stress model. Kaohsiung J. Medical Sci. 31 (2015), 605–612.
194. Zhang, H., et al. Central κ-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: Behavioral and BDNF mRNA expression studies. Eur. J. Pharmacol. 570 (2007), 89–96.
195. Zhang, J.Q., et al. Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway. Acta Pharmacol. Sin., 2016.
196. Zhu, S., et al. Unpredictable chronic mild stress not chronic restraint stress induces depressive behaviours in mice. Neuroreport 25 (2014), 1151–1155.